{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T15:27:52Z","timestamp":1782660472607,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.brachy.2025.09.011","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T17:51:38Z","timestamp":1760637098000},"page":"127-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Hayeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0094-0161","authenticated-orcid":false,"given":"Dimitriy","family":"Zamarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-6394","authenticated-orcid":false,"given":"Ying","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-1193","authenticated-orcid":false,"given":"Jessica","family":"Lowenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Ghamande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren","family":"Mell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-5381","authenticated-orcid":false,"given":"Laura L.","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8461-4568","authenticated-orcid":false,"given":"Cara","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-6586","authenticated-orcid":false,"given":"Allison","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-0501","authenticated-orcid":false,"given":"Elizabeth","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-6845","authenticated-orcid":false,"given":"Charles A.","family":"Leath III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin-E.","family":"O\u2019Cearbhaill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-3225","authenticated-orcid":false,"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell J.","family":"Schilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mayadev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.09.011_bib0001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: HDR Brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0002","unstructured":"International commission on radiation units and measurements (ICRU), dose and volume specification for reporting intracavitary therapy in gynecology, ICRU report No. Bethesda, MD, 1985."},{"key":"10.1016\/j.brachy.2025.09.011_bib0003","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.semradonc.2014.02.007","article-title":"MRI-guided brachytherapy","volume":"24","author":"Tanderup","year":"2014","journal-title":"Semi Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijrobp.2015.03.010","article-title":"Image-based brachytherapy for the treatment of cervical cancer","volume":"92","author":"Harkenrider","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0005","first-page":"1","article-title":"ICRU report No. 89 prescribing, recording, and reporting brachytherapy for cancer of the cervix","volume":"13","author":"Potter","year":"2013","journal-title":"J ICRU"},{"key":"10.1016\/j.brachy.2025.09.011_bib0006","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2025.09.011_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0360-3016(98)00267-3","article-title":"Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study","volume":"42","author":"Varia","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0008","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S1470-2045(23)00479-5","article-title":"Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial","volume":"24","author":"Monk","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0009","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2025.09.011_bib0010","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/cncr.33424","article-title":"Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety","volume":"127","author":"Williamson","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2025.09.011_bib0011","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41467-024-55200-2","article-title":"Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial","volume":"16","author":"Mayadev","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.brachy.2025.09.011_bib0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brachy.2016.03.008","article-title":"American brachytherapy task group report: a pooled analysis of clinical outcomes for high dose rate brachytherapy for cervical cancer","volume":"16","author":"Mayadev","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0013","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meddos.2010.02.009","article-title":"Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?","volume":"36","author":"Kim","year":"2011","journal-title":"Med Dosim"},{"key":"10.1016\/j.brachy.2025.09.011_bib0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2009.07.001","article-title":"Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy","volume":"93","author":"Dimopoulos","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"Potter","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.radonc.2013.04.006","article-title":"Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience","volume":"107","author":"Nomden","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0017","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0018","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","article-title":"Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer","volume":"83","author":"Potter","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0019","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijrobp.2014.10.053","article-title":"MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience","volume":"91","author":"Gill","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brachy.2014.01.004","article-title":"Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer","volume":"13","author":"Mayadev","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0021","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.brachy.2016.06.001","article-title":"Workflow efficiency for the treatment planning process in CT-guided high-dose-rate brachytherapy for cervical cancer","volume":"15","author":"Michaud","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0022","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2014.12.006","article-title":"A multicenter \u201cend to end\u201d dosimetry audit for cervix HDR brachytherapy treatment","volume":"114","author":"Palmer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0023","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.radonc.2015.08.001","article-title":"Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: final results of the EMBRACE study dummy run","volume":"117","author":"Kirisits","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0024","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2006.12.021","article-title":"Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours","volume":"68","author":"Viswanathan","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0026","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2020.10.038","article-title":"Brachytherapy quality assurance in the PORTEC-4a trial for molecular integrated risk profile guided adjuvant treatment of endometrial cancer","volume":"155","author":"Wortman","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0027","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.brachy.2020.03.007","article-title":"Peer-based credentialing for brachytherapy: application in permanent seed implant","volume":"19","author":"Meyer","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0028","first-page":"335","article-title":"Executive Summary of AAPM Report Task Group 113: guidance for the physics aspects of clinical trials","volume":"19","author":"Moran","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0029","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2011.12.080","article-title":"Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials-report of the National Cancer Institute Work Group on Radiotherapy Quality assurance","volume":"83","author":"Bekelman","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.brachy.2020.04.008","article-title":"A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer","volume":"19","author":"Yusufaly","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0031","unstructured":"https:\/\/www.aapm.org\/org\/structure\/default.asp?committee_code=TG425, Access date Aug 31, 2025. (AAPM TG-425)."},{"key":"10.1016\/j.brachy.2025.09.011_bib0032","unstructured":"https:\/\/www.nrgoncology.org>, Access date Aug 31, 2025. (NRG-GY037)."},{"key":"10.1016\/j.brachy.2025.09.011_bib0033","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ijrobp.2015.11.024","article-title":"Image guided Cervical brachytherapy: 2014 survey of the American Brachytherapy Society","volume":"94","author":"Grover","year":"2016","journal-title":"Int J Radiation Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0034","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2023.04.003","article-title":"Artificial intelligence applications in brachytherapy: A literature review","volume":"22","author":"Zhao","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.09.011_bib0035","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0036","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2010.11.039","article-title":"Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704\u2014A phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas","volume":"82","author":"Abrams","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0037","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijrobp.2013.03.036","article-title":"Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review","volume":"87","author":"Fairchild","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0038","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jnci\/djt001","article-title":"Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials","volume":"105","author":"Ohri","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2025.09.011_bib0039","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.09.011_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.09.011_bib0041","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.ejca.2012.06.002","article-title":"Do results of the EORTC dummy run predict the quality of radiotherapy delivered within multicentre clinical trials?","volume":"48","author":"Fairchild","year":"2012","journal-title":"Eur J Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:23:55Z","timestamp":1781177035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538472125003125"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.09.011","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}